Erkki Ruoslahti

Erkki Ruoslahti

Founder bij Cend Therapeutics, Inc.

Vermogen: 4 M $ op 31-03-2024

84 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Erkki Ruoslahti is the founder of Telios Pharmaceuticals, Inc. (founded in 1987), Targeted Molecules Corp.
(founded in 2000), and Cend Therapeutics, Inc. (founded in 2015).
He holds the title of Director at Telios Pharmaceuticals, Inc. from 1987 to 1995, Director at Targeted Molecules Corp.
from 2000 to 2002, and previously served as the Executive Chairman at Cend Therapeutics, Inc. Dr. Ruoslahti is also the founder of FIBRX Derm, Inc., Center For Nanomedicine, and Impilo Therapeutics, Inc. Dr. Ruoslahti's current job(s) include being a Professor at the University of California, Berkeley, a Member of the National Academy of Sciences, a Member of the American Academy of Arts & Sciences, a Member of the National Academy of Medicine (United States), and a Member of the European Molecular Biology Organization.
Dr. Ruoslahti's former job(s) include being the President & Chief Executive Officer of Sanford Burnham Prebys Medical Discovery Institute from 1976 to 2020, Director at Advance Technologies, Inc. from 2005 to 2008, Director at Canji, Inc. from 1993 to 1996, Independent Director at Astellas Institute for Regenerative Medicine from 2005 to 2011, Independent Director at Lisata Therapeutics, Inc. from 2022 to 2023, and Professor at the University of California, Santa Barbara from 2005 to 2015.
Dr. Ruoslahti obtained a doctorate degree from the University of Helsinki.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
17-04-2023 1 171 144 ( 14.10% ) 4 M $ 31-03-2024

Actieve functies van Erkki Ruoslahti

BedrijvenFunctieBegin
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
University of California, Berkeley Corporate Officer/Principal 01-07-2011
Founder 01-01-2015
European Molecular Biology Organization Corporate Officer/Principal -
Alle actieve functies van Erkki Ruoslahti

Eerdere bekende functies van Erkki Ruoslahti

BedrijvenFunctieEinde
LISATA THERAPEUTICS, INC. Director/Board Member 11-07-2023
Chief Executive Officer 01-09-2020
Founder 01-09-2020
░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Ervaring van Erkki Ruoslahti in detail bekijken

Opleiding van Erkki Ruoslahti

University of Helsinki Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Erkki Ruoslahti in detail bekijken

Connecties

100 +

Eerstegraads connecties

18

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit15

Health Technology

Advance Technologies, Inc.

Electronic Technology

Commercial Services

Health Services

Health Technology

Commercial Services

Commercial Services

Commercial Services

Health Services

European Molecular Biology Organization

Health Technology

Health Technology

Technology Services

Lisata Therapeutics, Inc.

Center For Nanomedicine

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Erkki Ruoslahti